Sanofi said on Friday that its multiple sclerosis drug candidate was shown to delay worsening of a progressive form of the ...

Blockbuster weight loss drugs have been arguably the biggest health story of the last several years — and there are no signs ...

Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart ...

Data from an early stage clinical trial suggests Novo Nordisk’s new weight loss pill amycretin could produce greater and more ...

A Swiss pharmaceutical company hoping to cash in on the weight loss drug trend is having its dreams dashed amid new trials ...

Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

The maker of injectable weight loss drugs including Ozempic and Wegovy is touting the results of an early-stage trial that delivered weight loss success by taking a daily pill.

The manufacturer of Ozempic is testing amycretin, an experimental weight-loss pill that appears to help people quickly shed ...

Twenty people are facing charges in connection to a drug trafficking ring that operated around the Sandusky area, the U.S. Department of Justice announced on Thursday.

Ozempic maker Novo Nordisk has developed a pill that can cause weight loss of up to 13% in three months, according to new ...

Postpartum depression can impact as many as one in five women and leads to extreme sadness or anxiety following childbirth. A pill approved by the FDA may help alleviate what can be a debilitating ...